United StatesBreaking News

GTCR Co-CEO and Managing Director Collin Roche reflects on the private equity landscape, emphasizing the importance of value creation over merely capitalizing on rising prices. Roche highlights GTCR's multibillion-dollar exit from Worldpay as a prime example of their strategy: backing executive teams to implement operational and strategic changes that improve business performance and justify higher exit multiples.

Gilead Sciences (NASDAQ:GILD) delivered a steady first quarter for 2026, as the company’s core HIV business and expanding oncology franchise provided a solid buffer against the continued normalization of pandemic-related product sales.

Bill Campbell, Doubleline Global, Sovereign and Emerging Markets Head, talks about how the war with Iran is impacting markets, a lasting inflation shock and making sure markets don't lose confidence in the Federal Reserve. He speaks on a special "Bloomberg The Close" from Los Angeles.

The Trump administration's fitful campaign to address US voters' affordability concerns ahead of the midterm elections is faltering, with some key efforts stalled, cast aside or limited in scope.  The war in Iran has driven up gas prices and sent a chill through the spring housing market. It has also drowned out the administration's set-piece events meant to highlight larger tax refunds and measures to lower drug prices. Liz Pancotti, Managing Director of Policy and Advocacy at the Groundwork Collaborative, discusses how consumers are experiencing a spending slowdown. She speaks with Bloomberg's Kailey Leinz on Balance of Power.

Rebecca Homkes, Lecturer at the London Business School joins Bloomberg Businessweek Daily to discuss how the war in the Middle East is changing the global outlook for Central Banks.

Hawkeye 360, a provider of satellite-based signals intelligence for US government agencies, raised $416 million in its US market debut. It's the latest sign that the IPO market is picking up steam. HawkEye 360 CEO John Serafini speaks with Caroline Hyde on "Bloomberg Tech."

Brittany Christensen, senior vice president and head of business development at Tidal Financial Group, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss recent reports that Fidelity Investments and Charles Schwab will start charging platform fees for the trading of certain ETFs.

Scarlet Fu and Eric Balchunas discuss abrdn Physical Precious Metals Basket Shares ETF (ticker: GLTR) on "Bloomberg ETF IQ."

Sean O'Hara, president of Pacer ETFs, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss Pacer Nasdaq International Patent Leaders ETF (ticker: PATN), which has a total return exceeding 70% since its launch in 2024.

Maital Legum, head of ETF solutions at Teucrium, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss the development of exchange traded products as US stocks hit record highs.

BioRestorative Therapies (NASDAQ:BRTX) announced significant clinical progress in its lead cell therapy program, BRTX-100, reporting expanded blinded Phase 2 data that demonstrates long-term efficacy for patients suffering from chronic lumbar disc disease (cLDD).

Wall Street bonuses are projected to jump for the third year in a row as market volatility fuels trading demand and dealmaking makes its long-awaited comeback. For investment bankers who advise corporate clients on deals, incentive pay is poised to be up 10% to 20% or more from a year earlier, according to Johnson Associates. Katherine Doherty has more.